Hyperinsulinemia in the polycystic ovary syndrome: A clinical, endocrine and echographic study in 240 patients

Gynecological Endocrinology

Volumn 10, Issue 5, 1996, Pages 319-326

  Falsetti, L ^a,b   Eleftheriou, G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NONE   (Italy)

Author keywords

Hyperandrogenism; Hyperinsulinemia; Obesity; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOCRINOLOGY; ESTRADIOL BLOOD LEVEL; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SECONDARY AMENORRHEA; SYMPTOM; TESTOSTERONE BLOOD LEVEL;

EID: 0029962492     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609012818     Document Type: Article

References (57)

1. Barbieri, R. L., Smith, S. and Ryan, K. J. (1988). The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril., 50, 197-212
2. Nestler, J. E., Powers, L. P., Matt, D. W., Steingold, K. A., Plymate, S. R., Rittmasster, R. S., Clore, J. N. and Blackard, W. G. (1991). A direct effect of hyperinsulinemia on serum sex hormonebinding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 72, 83-9
3. Bergh, C., Carlsson, B., Olsson, J. H., Selleskog, U. and Hillensjo, T. (1993). Regulation of androgen production in cultured human thecal cells by insulin-like growth factor 1 and insulin. Fertil. Steril, 59, 323-31
4. Ciaraldi, T. P., El-Roeiy, A., Madar, Z., Reichart, D., Olefsky, J. M. and Yen, S. S. C. (1992). Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 75, 577-82
5. Anttila, L., Koskinen, P., Jaatinen, T., Erkkola, R., Irjala, K. and Ruutiainen, K. (1993). Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum. Reprod., 8, 1179-83
6. Dunaif, A., Segal, K. R., Futterweit, W. and Dobrjansky, A. (1989). Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-73
7. Conway, G. S. and Jacobs, H. S. (1993). Clinical implications of hyperinsulinemia in women, Clin. Endocrinol. (Oxf.), 39, 623-32
8. Dunaif, A. (1994). Molecular mechanisms of insulin resistance in the polycystic ovary syndrome. Semin. Reprod. Endocrinol., 12, 15-20
9. Conway, G. S., Jacobs, H. S., Holly, J. M. P. and Wass, J. A. H. (1990). Effects of luteinizing hormone, insulin, insulin-growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 33, 593-603
10. Poretsky, L. and Kalin, M. F. (1987). The gonadotropic function of insulin. Endocr. Rev., 8, 132-41
11. Reis, R. M., Foss, M. C., Moura, M. D., Ferriani, R. A. and Silva de Sà, M. F. (1995). Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism. Gynecol. Endocrinol., 9, 45-50
12. Sutterlin, M. and Steck, T. (1995). Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism. Gynecol. Endocrinol., 9, 37-44
13. Falcone, T., Finedood, D. T., Fantus, G. and Morris, D. (1990). Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women. J. Clin. Endocrinol. Metab., 71, 1653-7
14. Plymate, S. R., Fariss, B. L., Bassett, M. L. and Matej, L. (1981). Obesity and its role in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 52, 1246-8
15. Pasquali, R., Antenucci, D., Casimirri, F., Venturoli, F., Paradisi, R., Fabbri, R., Balestra, V., Melchionda, N. and Barbara, L. (1989). Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab., 68, 173-8
16. Bonadonna, R. C., Groop, L., Kraemer, N., Ferrannini, E., Del Prato, S. and De Fronzo, R. A. (1990). Obesity and insulin resistance in humans: a dose-response study. Metabolism, 39, 452-9
17. Kiddy, D. S., Sharp, P. S., White, D. M., Scanlon, M. F., Mason, H. D., Bray, C. S., Poison, D. W., Reed, M. J. and Franks, S. (1990). Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.), 32, 213-20
18. Dale, P. O., Tanbo, T., Vaaler, S. and Abyholm, T. (1992). Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril., 58, 487-91
19. Smith, S., Ravnikar, V. A. and Barbieri, R. (1987). Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril., 48, 72-7
20. Shoham, Z., Jacobs, H. S. and Insler, V. (1993). Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil. Steril., 59, 1153-61
21. Ruutiainen, K. and Adashi, E. Y. (1993). Intraovarian factors in hyperandrogenism. Semin. Reprod. Endocrinol., 11, 324-8
22. Homburg, R., Pariente, C., Lunenfeld, B. and Jacobs, H. S. (1992). The role of insulin growth factor-I (IGF-I) and IGF binding protein-1 (IGFBP-I) in the pathogenesis of polycystic ovary syndrome. Hum. Reprod., 7, 1379-83
23. Sharp, P. S., Kiddy, D. S., Reed, M. J., Anyaoku, V., Johnston, D. G. and Franks, S. (1991). Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 35, 253-7
24. Suikkari, A. M., Ruutiainen, K., Erkkola, R. and Seppala, M. (1989). Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum. Reprod., 4, 136-9
25. Pekonen, F., Laatikainen, T., Buyalos, R. and Rutanen, E. (1989). Decreased 34K insulin-like growth factor binding protein in polycystic ovary disease. Fertil. Steril., 51, 972-5
26. Jig Lee, E., Seok Lee, B., Chul Lee, H., Hyun Park, K., Song, C. and Huh, K. B. (1993). Growth hormone response to L-dopa and pyridostogmine in women with polycystic ovarian syndrome. Fertil. Steril., 60, 53-7
27. Aleem, F. A. and McIntosh, T. (1984). Elevated plasma levels of beta-endorphins in a group of women with polycystic ovarian disease. Fertil. Steril., 42, 686-9
28. Adams J., Poison, D. W., Abdulwahid, N., Morris, D. V., Franks, S., Mason, H. D., Tucker, M. and Price, J. (1985). Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, 2, 1375-8
29. National Diabetes Data Group (1979). Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-57
30. Adashi, E. Y., Hsueh, A. J. W. and Yen, S. S. C. (1981). Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology, 108, 1441-9
31. Worttsman, J., Weherberger, W. B., Gavin, J. R. and Allen, J. (1984). Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet. Gynecol., 63, 630-4
32. Weaver, J. U., Kopelman, P. G., McLoughlin, L., Forsling, M. L. and Grossman, A. (1993). Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.), 39, 345-50
33. Chappel, S. C., Resco, J. A., Norman, R. L. and Spies, H. G. (1981). Studies in rhesus monkeys on the site where estrogen inhibits gonadotropins: delivery of 17 beta estradiol to the hypothalamus and pituitary gland. J. Clin. Endocrinol. Metab., 52, 1-8
34. Poretsky, L., Grigorescu, F., Seibel, M., Moses, A. C. and Flier, J. S. (1985). Distribution and characterization of insulin and insulin-like growth factor 1 receptors in normal human ovary. J. Clin. Endocrinol. Metab., 61, 728-34
35. Insler, V., Shoham, Z., Barash, A., Koistinen, R., Seppala, M., Hen, M., Lunenfeld, B. and Zadik, Z. (1993). Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings, Hum. Reprod., 8, 379-84
36. Erickson, G. F., Magoffin, D. A., Dyer, C. A. and Hofeditz, C. (1985). The ovarian androgen producing cells: a review of structure/function relationships. Endocr. Rev., 6, 371-99
37. Cara, J. and Rosenfield, R. L. (1988). Insulin-like growth factor 1 and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology, 123, 733-9
38. Rosenfield, R. L., Barnes, R. B., Cara, J. and Lucky, A. W. (1990). Dysregulation of cytochrome P450c17a as the cause of polycystic ovarian syndrome. Fertil. Steril., 53, 785-91
39. Dunaif, R., Mandeli, J., Fluhr, H. and Dobrjansky, A. (1988). The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 66, 131-9
40. Buyalos, R. P., Geffner, M. E., Watanabe, R. M., Bergman, R. N., Gornbein, J. A. and Judd, H. L. (1993). The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil. Steril., 60, 626-33
41. Lobo, R. A. (1991). Hirsutism in polycystic ovary syndrome: current concepts. Clin. Obstet. Gynecol., 34, 817-25
42. McKenna, T. J. (1993). Variable androgen sensitivity in relationship to hirsutism and acne. Clin. Endocrinol. (Oxf.), 39, 547-9
43. Bridges, N. A., Cooke, A., Healy, M. J. R., Hindmarsh, P. C. and Brook, C. G. D. (1993). Standards for ovarian volume in childhood and puberty. Fertil. Steril., 60, 456-60
44. Polson, D. W., Adams, J., Wadsworth, J. and Franks, J. (1988). Polycystic ovaries: a common finding in normal women. Lancet, 1, 870-2
45. Clayton, R. N., Ogden, V., Hodgkinson, J., Worswick, L., Rodin, D. A., Dyer, S. and Meade, T. W. (1992). How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol. (Oxf.), 37, 127-33
46. Shoham, Z., Conway, G. S., Patel, A. and Jacobs, H. S. (1992). Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil. Steril., 58, 37-47
47. Franks, S. (1989). Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.), 31, 87-120
48. Guzick, D. S., Wing, R., Smith, D., Berga, S. L. and Winters, S. J. (1994). Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil. Steril., 61, 598-604
49. Bates, G. W. and Whitworth, N. S. (1982). Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil. Steril., 38, 406-9
50. Kiddy, D. S., Hamilton-Fairley, D., Bush, A., Short, F., Anyaoku, V. and Reed, M. J. (1992). Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 36, 105-11
51. Fulghesu, A. M., Lanzone, A., Cucinelli, F., Caruso, A. and Mancuso, S. (1993). Long term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovarian disease. Obstst. Gynecol., 82, 191-7
52. Lanzone, A., Fulghesu, A. M., Fortini, A., Cutillo, G., Cucinelli, F., Di Simone, N., Caruso, A. and Mancuso, S. (1991). Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum. Reprod., 6, 1043-9
53. Fulghesu, A. M., Ciampelli, M., Fortini, A., Cucinelli, F., Guido, M., Caruso, A., Lanzone, A. and Mancuso, S. (1995). Effect of opioid blockade on insulin metabolism in polycystic ovarian disease. Hum. Reprod., 10, 2253-7
54. Taylor, S. I., Dons, R. F., Hernandez, E., Roth, J. and Gorden, P. (1982). Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann. Intern. Med., 97, 851-5
55. Dunaif, A., Segal, K. R., Shelley, D. R., Green, G., Dobrjansky, A. and Licholai, T. (1992). Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1257-66
56. Rosenbaum, D., Haber, R. S. and Dunaif, A. (1993). Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am. J. Physiol., 264, E197-202
57. Clausen, J., Hansen, T., Bjobaek, C., Echwald, S., Urhammer, S., Rasmussen, S., Andersen, C., Hansen, L., Almind, K., Winter, K., Haraldsdottir, J. and Borch-Johnsen, K. (1995). Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet, 346, 397-402